glp 1 agonists for type 2 diabetes GLP-1 receptor are increasingly used to treat and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read GLP-1 receptor agonist use does

In a motion to dismiss the lawsuit last year, lawyers for Mochi Health called the complaint part of a nationwide campaign to bolster Lillys profits by dictating patient care through the elimination of compounded drugs as a treatment option for weight management. The lawsuit is ongoing

Clin Obes

Harkavyi A, Rampersaud N, Whitton PS

Think about the incredible things it does with such precision and efficiency

Various methods were employed to measure gastric emptying in studies that included patients taking different GLP-1 medications, including both long-acting and short-acting formulations

A., A Prospective, ClaimsBased Assessment of the Risk of Pancreatitis and Pancreatic Cancer With Liraglutide Compared to Other Antidiabetic Drugs, Diabetes, Obesity & Metabolism 16 (2014): 273275